Bladder Cancer (1)

Bladder Transitional Cell Carcinoma (1)

Fibroblast Growth Factor Receptor (1)

Withdrawn (1)

phase 1 (1)

Guru P. Sonpavde (1)

QED Therapeutics, Inc. (1)

infigratinib (1)

drug (1)

Other (1)

Interventional (1)

Bladder Transitional Cell Carcinoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Withdrawn

Aug 8, 2022